0
MEI Pharma, Inc. Banner Image

MEI Pharma, Inc.

  • Ticker MEIP
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
MEI Pharma, Inc. Logo Image
  • 51-200 Employees
  • Based in San Diego, California
MEI Pharma, Inc. (NASDAQ: MEIP) is a late-stage pharmaceutical company focused on developing potential new therapies for cancer. MEI Pharma's portfolio of drug candidates contains four clinical-stage assets, including zandelisib, currently in an ongoing Phase 2 clinical trial which may support an accelerated approval marketing application with the U.S. Food and Drug Administration. EachMore of MEI Pharma's pipeline candidates leverages a different mechanism of action with the objective of developing therapeutic options that are: (1) differentiated, (2) address unmet medical needs and (3) deliver improved benefit to patients either as standalone treatments or in combination with other therapeutic options.
MEI Pharma, Inc.

Most Recent Responsibility Report

MEI Pharma, Inc.
MOST RECENT 2022 ESG Report

MEI Pharma, Inc. does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information
Our service enables potential investors to review the most recent and archived MEI Pharma, Inc. Sustainability Report, MEI Pharma, Inc. Corporate Social Responsibility Report, MEI Pharma, Inc. CSR Report, MEI Pharma, Inc. Corporate Responsibility, MEI Pharma, Inc. CR Report, MEI Pharma, Inc. Citizenship Report, MEI Pharma, Inc. ESG Report, and MEI Pharma, Inc. Environmental Report online.
MEI Pharma, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!